19-05-2003 Comments (0)
Aventis PharmaBaxterBaxter Biopharma SolutionsBaxter Healthcare Corporation's BioPharma SolBaxter InternationalLevaquinLevofloxacinLevofloxacin Ophthalmic Solution 0.5%NystatinOralQuinupristin and DalfopristinQuixinSynercid
Tokyo saw an extended gain in the week ended May 12. Opening higher on expectations of the unveiling…
A trial subscription will give you access to the latest news on The Pharma Letter for 7 days, in order to evaluate the paid service.